Genetic Mechanisms in Anterior Segment Dysgenesis

Anterior segment dysgenesis encompasses a spectrum of developmental anomalies affecting the cornea, iris, lens and aqueous drainage structures of the eye. Central to its pathogenesis is the disruption of gene networks that govern neural crest cell migration, differentiation and extracellular matrix remodelling. Transcription factors such as FOXC1 and PITX2 play pivotal roles in orchestrating craniofacial and ocular morphogenesis through precise regulation of target genes. Variants in these factors—ranging from missense changes within homeodomains to truncating mutations—often result in haploinsufficiency or altered transcriptional activity, leading to malformations such as Axenfeld–Rieger syndrome and Peters anomaly. Additional players include PAX6, a master regulator of eye formation, and CYP1B1, an enzyme implicated in anterior chamber angle development. Emerging evidence highlights the contribution of non-coding regulatory elements, where single-nucleotide changes can perturb enhancer activity and dysregulate downstream pathways such as retinoic acid signalling. The considerable clinical heterogeneity observed in anterior segment dysgenesis reflects the interplay between gene dosage effects, modifier loci and epigenetic factors. Improved understanding of these genetic mechanisms informs early diagnosis, genetic counselling and the pursuit of targeted therapies aimed at preserving vision and reducing the risk of secondary glaucoma.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Genetic Mechanisms in Anterior Segment Dysgenesis publication trend

The graph below shows the total number of articles in genetic mechanisms in anterior segment dysgenesis across all publications each year (not limited to Nature Index journals).

Technical terms

Anterior segment dysgenesis: Developmental malformation of the front part of the eye involving cornea, iris, lens and drainage structures.

Haploinsufficiency: A condition in which a single functional copy of a gene is insufficient to maintain normal function.

Homeodomain transcription factor: A protein containing a conserved DNA-binding domain that regulates gene expression during development.

Neural crest cells: A multipotent embryonic cell population that migrates to form diverse tissues including ocular anterior segment structures.

Regulatory element: A non-coding DNA sequence, such as an enhancer or silencer, that modulates transcription of target genes.

References

1. FOXC1 Transcriptional Regulation Is Mediated by N- and C-terminal Activation Domains and Contains a Phosphorylated Transcriptional Inhibitory Domain*. Journal of Biological Chemistry (2002).
2. Whole exome sequencing identifies a heterozygous missense variant in the PRDM5 gene in a family with Axenfeld–Rieger syndrome. Neurogenetics (2015).
3. A Novel Homozygous Mutation in FOXC1 Causes Axenfeld Rieger Syndrome with Congenital Glaucoma. PLOS ONE (2016).
4. Axenfeld‐Rieger Syndrome Associated with Congenital Glaucoma and Cytochrome P4501B1 Gene Mutations. Case Reports in Medicine (2010).